<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT942-10434</title>
	</head>
	<body>
		<main>
			<p>940511 FT  11 MAY 94 / World News in Brief: SmithKline Beecham The Anglo-US drugs company is to launch an unbranded version of its former best-selling ulcer drug Tagamet in the US, in an attempt to stave off competition from cut-price generic products after the expiry of Tagamet's US patent on May 17. Page 27; Industry seeks prescription for growth, Page 32</p>
		</main>
</body></html>
            